82
Participants
Start Date
January 31, 2016
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
Exenatide
6 hour IV infusion (double infusion of 0.1250 mcg/kg/hour for 30 min followed by infusion rate (1X) of 0.0625 mcg/kg/hour for 5.5 hours).
Placebo
6 hour IV infusion.
Moxifloxacin
400 mg oral dose moxifloxacin within 1 min of start of infusion of exenatide
Palonosetron
0.25 mg administered IV within 30 minutes prior to initiating the infusion of exenatide
PRA-Groningen, Groningen
Lead Sponsor
Intarcia Therapeutics
INDUSTRY